Oramed Pharmaceuticals
ORMP
#9090
Rank
C$0.16 B
Marketcap
C$4.18
Share price
4.66%
Change (1 day)
17.47%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : C$11.15 Million

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are C$11.15 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$14.25 M-81.37%
2023-12-31C$76.47 M437.46%
2022-12-31C$14.22 M
2021-08-31C$14.48 M-5.45%
2020-08-31C$15.32 M-24.91%
2019-08-31C$20.4 M-4.12%
2018-08-31C$21.28 M-12.38%
2017-08-31C$24.28 M11.34%
2016-08-31C$21.81 M987.63%
2015-08-31C$2 M82.76%
2014-08-31C$1.09 M97.22%
2013-08-31C$0.55 M-63.05%
2012-08-31C$1.5 M155.76%
2011-08-31C$0.58 M-10.86%
2010-08-31C$0.66 M16.05%
2009-08-31C$0.56 M-41.69%
2008-08-31C$0.97 M-35.01%
2007-08-31C$1.5 M123.4%
2006-08-31C$0.67 M1133.82%
2005-08-31C$0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$1.61 B 14,395.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$74.13 B 664,499.43%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$90.92 B 814,948.76%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
C$74.38 M 566.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
C$0.11 B 958.73%๐Ÿ‡บ๐Ÿ‡ธ USA